A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients

American Journal of Kidney Diseases

Volumn 33, Issue 4, 1999, Pages 694-701

  Bleyer, A J ^a   Burke, S K ^a   Dillon, M ^a   Garrett, B ^a   Kant, K S ^a   Lynch, D ^a   Rahman, S N ^a   Schoenfeld, P ^a   Teitelbaum, I ^a   Zeig, S ^a   Slatopolsky, E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hemodialysis; Hypercholesterolemia; Hyperparathyroidism; Hyperphosphatemia; Sevel amer

Indexed keywords

ALUMINUM; CALCITRIOL; CALCIUM; CALCIUM ACETATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHOSPHATE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0032944582     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70221-0     Document Type: Article

References (31)

1. SH Hou J Zhao CF Ellman J Hu Z Griffin DM Spiegel JE Bourdeau Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate Am J Kidney Dis 18 1991 217 224
2. DR Salomon WE Mitch Therapy of disordered divalent ion metabolism in chronic renal failure BM Brenner JH Stein Contemporary Issues in Nephrology: Divalent Ion Homeostasis 1983 Churchill Livingstone New York, NY 319 355
3. DL Makoff A Gordon SS Franklin AR Gerstein MH Maxwell Chronic calcium carbonate therapy in uremia Arch Intern Med 123 1969 15 21
4. BF Boyce GS Fell HY Elder BJ Junor HL Elliot G Beastall I Fogelman IT Boyle Hypercalcaemic osteomalacia due to aluminium toxicity Lancet 2 1982 1009 1013
5. AC Alfrey GR LeGendre WD Kaehney The dialysis encephalopathy syndrome: Possible aluminum intoxication N Engl J Med 294 1976 184 188
6. E Slatopolsky C Weerts S Lopez-Hilker K Norwood M Zink D Windus J Delmez Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis N Engl J Med 315 1986 157 161
7. M Emmett MD Sirmon WG Kirkpatrick CR Nolan GW Schmitt MV Cleveland Calcium acetate control of serum phosphorus in hemodialysis patients Am J Kidney Dis 17 1991 544 550
8. DL Andress KC Norris JW Coburn EA Slatopolsky D Sherrard Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure N Engl J Med 321 1989 274 279
9. SL Burke EA Slatopolsky DI Goldberg Renagel, a novel calcium- and aluminum-free phosphate binder, inhibits phosphate absorption in normal volunteers Nephrol Dial Transplant 12 1997 1640 1644
10. GM Chertow SK Burke JM Lazarus KH Stenzel D Wombolt D Goldberg JV Bonventre E Slatopolsky Poly[allylamine Hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure Am J Kidney Dis 29 1997 66 71
11. EA Slatopolsky SK Burke MA Dillon the RenaGel Study Group RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone Kidney Int 55 1999 299 307
12. BM Posner CL Borman JL Morgan WS Borden J Ohls The validity of a telephone-administered 24-hour dietary recall methodology Am J Clin Nutr 36 1982 546 553
13. R Kumar Calcium disorders ed 3 J Kokko R Tannen Fluids and Electrolytes 1996 Saunders Philadelphia, PA 391 419
14. M Nauck A Kramer-Guth W Bartens W Marz H Wieland C Wanner Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients? Clin Nephrol 46 1996 319 325
15. TCB Stamp JM Round Seasonal changes in human plasma levels of 25-hydroxyvitamin D Nature 247 1974 563 565
16. SA Friedman S Novack GE Thomson Arterial calcification and gangrene in uremia N Engl J Med 280 1969 1392 1394
17. MM Salem Hyperparathyroidism in the hemodialysis population: A survey of 612 patients Am J Kidney Dis 29 1997 862 865
18. F Meric P Yap MJ Bia Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy Am J Kidney Dis 5 1990 459 464
19. AJ Felsenfield F Llach Parathyroid gland function in chronic renal failure Kidney Int 43 1993 771 789
20. J Molgaard H von Schenck AG Olsson Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolemia Eur J Clin Pharmacol 36 1989 455 460
21. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in incidence of coronary heart disease JAMA 251 1984 351 364
22. JL Probstfield BE Statland L Gorman DB Hunninghake Alterations in human serum alkaline phosphatase and its isoenzymes by hypolipidemic agents: Colestipol and clofibrate Metabolism 32 1983 818 821
23. J Bommer E Strohbeck J Goerich M Bahner I Zuna Arteriosclerosis in dialysis patients Int J Artif Organs 19 1996 638 644
24. U.S. Renal Data System, USRDS 1997 Annual Data Report April 1997 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 93
25. Scandinavian Simvastatin Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
26. The Lovastatin Study Group III A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia JAMA 260 1988 359 366
27. K Nakagawa A study of aortic calcification in uremia. Nippon Jinzo Gakkai Shi Japanese Journal of Nephrology 39 1997 135 143
28. AI Katz CL Hampers JP Merrill Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure Medicine 48 1969 333 377
29. RC Detrano ND Wong W Tang WJ French D Georgiou E Young OS Brezden TM Doherty KA Narahara BH Brundage Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects J Am Coll Cardiol 24 1994 354 358
30. L Wexler B Brundage J Crouse R Detrano V Fuster J Maddahi J Rumberger W Stanford R White K Taubert Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professions from the American Heart Association Circulation 94 1996 1175 1192
31. R Danielson H Sigvaldason G Thorgeirsson N Sigfussion Predominance of aortic calcification as an atherosclerotic manifestation in women: The Reykjavik Study J Clin Epidemiol 3 1996 383 387